- Meeting abstract
- Open Access
Randomized controlled trial of the effectiveness of an email-based alcohol intervention among university students: dismantling the assessment and feedback components
© Bendtsen et al; licensee BioMed Central Ltd. 2012
- Published: 9 October 2012
- Alcohol Intervention
- Unselected Population
- Main Trial
- Student Health
- Drinking Status
University students in Sweden routinely receive e-mail–based alcohol interventions sent from student health services. Earlier trials have examined the effectiveness of these interventions in simple parallel group designs. This exploratory study was undertaken in preparation for a larger trial. Using a dismantling design, we randomized 5227 students to either routine assessment and feedback (Group 1); assessment-only without feedback (Group 2); or no assessment and no feedback (Group 3). At baseline, all participants were blinded to study participation, with no contact made with Group 3. At 6-8 week follow-up, students were approached to participate in a cross-sectional alcohol study. Overall, 45% (N = 2336) of those targeted for study completed follow-up. Attrition was similar in Groups 1 and 2 (approximately 41% retained) but somewhat lower in Group 3 (52% retained). Intention-to-treat analyses among all participants, regardless of their baseline drinking status, revealed no differences between groups. Per-protocol analyses of Groups 1 and 2 among those who accepted the e-mail intervention offer (approximately 37%) and who screened positive for risky drinking (62% follow-up rate) suggested small beneficial effects on weekly consumption attributable to feedback. E-mail offer of alcohol intervention alone in an unselected population of university students was not found to be beneficial, although between-group differences in attrition prevent strong conclusions. Small benefits may follow actual uptake of e-mailed feedback intervention. The design of the main trial was positively influenced by data from this unusually large pilot study.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.